BALCO Medical Centre Wins FICCI Healthcare Excellence Award
13th October 2025
Raipur, Chhattisgarh | October 2025: BALCO Medical Centre (BMC), Central India’s leading cancer care hospital, has been honoured with the prestigious FICCI Healthcare Excellence Award 2025 in the category of Patient Care and Service Delivery.
The award recognises BMC’s initiative “Care Beyond Treatment: Holistic Support System for Cancer Patients”, which addresses key barriers faced by low-income and rural patients in continuing cancer treatment such as financial, nutritional, accommodation, and transport challenges.
The award was presented by Shri Rajiv Gauba, Member, NITI Aayog and Former Cabinet Secretary, Government of India along with the FICCI Jury members and was received by Dr. Bhawna Sirohi, Medical Director, Vedanta Medical Research Foundation, Naya Raipur.
Through Care Beyond Treatment, BMC has created a comprehensive ecosystem that extends far beyond hospital walls. The initiative includes:
- Sukh Sarai, a 95-bed subsidised accommodation for patients and caregivers offering meals, RO water, and transport.
- Free transport services, including e-rickshaws and a hospital bus connecting key transit points.
- High-protein diet support for patients undergoing chemotherapy.>
- BMC Charitable Fund for diagnostics and treatment gap funding not covered under government schemes.
- Partnerships with corporates, NGOs, and charitable foundations to sustain funding and enhance service reach.
The initiative has led to measurable impact—reducing treatment dropouts, improving compliance, and ensuring holistic care with dignity for every patient.
In recognition of its commitment to quality and compassion, the FICCI jury noted that BMC’s model “successfully integrates medical excellence with social responsibility, ensuring equitable access to advanced cancer care for underprivileged communities.”
Speaking on the occasion, Dr. Bhawna Sirohi, Medical Director of Vedanta Medical Research Foundation, said: “World-class cancer care is meaningful only when it is accessible to everyone, especially the most vulnerable. The ‘Care Beyond Treatment’ initiative reflects our belief that no one should discontinue treatment because of poverty or lack of support. It is a privilege to be recognised by FICCI for this prestigious award. FICCI stands for excellence and benchmarking in our country, and it was an honour to present to the FICCI board the depth and scale of work we are doing at BMC. Platforms like these help us set new benchmarks, share knowledge, and collaborate with like-minded individuals who are committed to improving patient care.”
“We plan to expand ‘Care Beyond Treatment’ project with several new initiatives — upgrading Sukh Sarai into a 250-bed Dharamshala, enhancing transportation frequency, extending nutritional support to all in-patients, and launching a Mobile Blood Donation Van for patients with thalassemia and sickle cell disease, added Mrs Jyoti Agarwal, Chairperson, Vedanta Medical Research Foundation. She further added, “We also aim to double our cancer screening and strengthen Cervical Cancer Elimination drive across Chhattisgarh. Such recognition from FICCI inspires and fuels us to do even more for those who need our support the most.”
Established as a not-for-profit, state-of-the-art 170 bed cancer hospital in Naya Raipur, BALCO Medical Centre is transforming cancer care in central India by combining world-class treatment with empathy, accessibility, and community-driven support.
About Vedanta Limited:
Vedanta Limited, a subsidiary of Vedanta Resources Limited, is one of the world’s leading Oil & Gas and Metals company with significant operations in Oil & Gas, Zinc, Lead, Silver, Copper, Iron Ore, Steel, and Aluminium & Power across India, South Africa and Namibia. For two decades, Vedanta has been contributing significantly to nation building. Governance and sustainable development are at the core of Vedanta's strategy, with a strong focus on health, safety, and environment. Vedanta has put in place a comprehensive framework to be the ESG leader in the natural resources sector. Vedanta is committed to reducing carbon emissions to zero by 2050 or sooner and has pledged $5 billion over the next 10 years to accelerate the transition to net zero operations. Giving back is in the DNA of Vedanta, which is focused on enhancing the lives of local communities. The company’s flagship social impact program, Nand Ghars, have been set up as model anganwadis focused on eradicating child malnutrition, providing education, healthcare, and empowering women with skill development. Under the aegis of the Anil Agarwal Foundation, the umbrella entity for Vedanta’s social initiatives, the Vedanta group has pledged Rs 5000 crore over the next five years on social impact programmes with a thrust on nutrition, women & child development, healthcare, animal welfare, and grass-root level sports. Vedanta and the group companies have been featured in Dow Jones Sustainability Index, and was conferred Frost & Sullivan Sustainability Awards 2020, Golden Peacock Award for excellence in Corporate Governance 2022 and certified as a Great Place to Work 2022. Vedanta Limited is listed on the Bombay Stock Exchange and the National Stock Exchange.
For more information, please visit www.vedantalimited.com
About Vedanta Aluminium Business:
Vedanta Aluminium, a business of Vedanta Limited, is India’s largest producer of aluminium, manufacturing more than half of India’s aluminium i.e., 2.37 million tonnes in FY24. It is a leader in value-added aluminium products that find critical applications in core industries. Vedanta Aluminium ranks 1st in the S&P Global Corporate Sustainability Assessment 2023 world rankings for the aluminium industry, a reflection of its leading sustainable development practices. With its world-class aluminium smelters, alumina refinery and power plants in India, the company fulfils its mission of spurring emerging applications of aluminium as the ‘Metal of the Future’ for a greener tomorrow.
For more information, please log on to www.vedantaaluminium.com
Follow us on LinkedIN, Facebook, Twitter, Instagram
Disclaimer:
This press release contains “forward-looking statements” – that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance, and often contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “should” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. For us, uncertainties arise from the behaviour of financial and metals markets including the London Metal Exchange, fluctuations in interest and or exchange rates and metal prices; from future integration of acquired businesses; and from numerous other matters of national, regional, and global scale, including those of a political, economic, business, competitive or regulatory nature. These uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements.
